FeesSafety
Pluang+
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

ARK Innovation ETF (ARKK) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Volvo to cut 2,500 jobs after Q3 loss due to weak China, US markets

Volvo Cars announced plans to cut 2,500 jobs following a sharp decline in earnings for the third quarter. The company reported an operating loss of 5.6 billion Swedish Kronor ($563.7 million), a significant drop from a 6.4 billion Kronor profit in th...

Market News
4 hours ago
CNBC
Bearish
news icon
Volvo to cut 2,500 jobs after Q3 loss due to weak China, US markets

Steriwave cuts surgical-site infections by 51.5% at Canada's largest cardiac center, boosting patient safety.

Ondine Biomedical's Steriwave antimicrobial treatment reduced surgical-site infections by 51.5% at the University of Ottawa Heart Institute, Canada's largest cardiac center, dropping infection rates from 3.3% to 1.6% in 2,172 procedures. Patient comp...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Steriwave cuts surgical-site infections by 51.5% at Canada's largest cardiac center, boosting patient safety.

Enozertinib shows strong results in first-line NSCLC with EGFR atypical mutations, advancing to global Phase 3 trial in 2027

ORIC Pharmaceuticals announced promising Phase 1b data for enozertinib in first-line NSCLC patients with EGFR atypical mutations, showing an 84% systemic response rate and 70% intracranial response rate despite high baseline brain metastases. The dru...

Market News
4 hours ago
GlobeNewsWire
Bullish
news icon
Enozertinib shows strong results in first-line NSCLC with EGFR atypical mutations, advancing to global Phase 3 trial in 2027

Rinzimetostat shows promise enhancing prostate cancer treatment by boosting sensitivity to androgen receptor inhibitors.

ORIC Pharmaceuticals presented preclinical and patient data at ESMO Congress 2026 showing that rinzimetostat, a PRC2 inhibitor targeting EED, may improve prostate cancer treatment by increasing tumor sensitivity to androgen receptor (AR) inhibitors. ...

Market News
4 hours ago
GlobeNewsWire
Bullish
news icon
Rinzimetostat shows promise enhancing prostate cancer treatment by boosting sensitivity to androgen receptor inhibitors.

Rio Tinto invests $1.9B to expand Queensland bauxite, boosting Weipa output by 2032

Rio Tinto is investing $1.9 billion to develop the Kangwinan bauxite project in Queensland, aiming to increase annual production capacity by 20 million tonnes and extend the life of its Weipa Operations. The project will replace output from the aging...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Rio Tinto invests $1.9B to expand Queensland bauxite, boosting Weipa output by 2032

Aduro Clean Technologies to present advances and engage investors at five key industry conferences through end of 2026

Aduro Clean Technologies announced its participation in five major industry and investor conferences from October to December 2026. The company will showcase progress in its Hydrochemolytic™ technology for recycling plastics and upgrading crude oils,...

Market News
6 hours ago
Na
Bullish
news icon
Aduro Clean Technologies to present advances and engage investors at five key industry conferences through end of 2026

Aduro Clean Technologies to present at five industry and investor conferences by end of 2026

Aduro Clean Technologies announced it will participate in five conferences between October and December 2026, engaging with industry professionals and institutional investors. Key topics include updates on their Hydrochemolytic™ technology for recycl...

Market News
6 hours ago
Na
Bullish
news icon
Aduro Clean Technologies to present at five industry and investor conferences by end of 2026

Tortoise AI Infrastructure ETF rated neutral short-term amid memory stock risks and market uncertainties

Tortoise AI Infrastructure ETF (TCAI) is rated neutral in the short term due to recent underperformance and challenges in AI infrastructure components, especially memory stocks which make up 17% of the fund but nearly 45% of expected earnings. Risks ...

Market News
6 hours ago
Seeking Alpha
Neutral
Tortoise AI Infrastructure ETF rated neutral short-term amid memory stock risks and market uncertainties

Oil prices rise on war risk premium amid threats to Saudi and Iranian infrastructure, Brent hits highest since May.

Oil prices are climbing due to increased war risk premiums as threats of strikes on Iran and attacks on Saudi oil infrastructure escalate. Brent crude settled at $113.17, its highest since early May, driven by tight supply and geopolitical tensions. ...

Market News
6 hours ago
FXEmpire
Bullish
news icon
Oil prices rise on war risk premium amid threats to Saudi and Iranian infrastructure, Brent hits highest since May.

inDrive to test Pony.ai robotaxis in Kazakhstan by 2027 with Nvidia AI tech support

Ride-hailing company inDrive is partnering with Chinese autonomous vehicle firm Pony.ai and Nvidia to test robotaxis in Kazakhstan starting in 2027. The tests will begin in Astana with safety operators, aiming for fully driverless rides eventually. P...

Market News
7 hours ago
TechCrunch
Bullish
news icon
inDrive to test Pony.ai robotaxis in Kazakhstan by 2027 with Nvidia AI tech support
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $7.92B
  • Volume
    3,264,054
  • Sector
    -
  • 52W High
    $92.78
  • 52W Low
    $63.52
  • Typical Hold Time
    113 Days
  • Enterprise Value
    -
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$82.14
52W Low: $63.52
30 Mar 2026
52W High: $92.78
05 Oct 2026

Track ARK Innovation ETF (ARKK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ARK Innovation ETF has traded between a low of $63.52 and a high of $92.78, highlighting its annual price range. Buy and sell ARK Innovation ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!